Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1979 May;63(5):885–892. doi: 10.1172/JCI109388

Immune function in systemic lupus erythematosus. Impairment of in vitro T-cell proliferation and in vivo antibody response to exogenous antigen.

A B Gottlieb, R G Lahita, N Chiorazzi, H G Kunkel
PMCID: PMC372029  PMID: 312809

Abstract

Peripheral blood mononuclear cells from 46 systemic lupus erythematosus (SLE) patients showed reduced ability to proliferate in vitro in response to the soluble antigen, tetanus toxoid, as compared with 96 normal controls. Special studies of 27 untreated SLE patients also revealed significantly decreased blastogenic responses to tetanus toxoid. In both the total and untreated SLE populations, decreased mean tetanus antibody titers also were found as compared with the control population. However, the reduction in antibody titer and blastogenic response was not strictly parallel. A limited immunization program was initiated in low-responding volunteers from the SLE and normal populations. Three out of four SLE patients did not develop a significant blastogenic response despite increases in anti-tetanus titers after immunization, whereas all normals showed significant increases in both blastogenic and antibody responses. The accumulated evidence indicated that the unresponsiveness was the result of a defect in T-cell function. Monocyte reactivity was demonstrated to be normal, and no evidence was found for the presence of suppressor cells, inhibition by immune complexes, or increased prostaglandins to explain the defect.

Full text

PDF
889

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abe T., Homma M. Immunological reactivity in patients with systemic lupus erythematosus. Humoral antibody and cellular immune responses. Acta Rheumatol Scand. 1971;17(1):35–46. doi: 10.3109/rhe1.1971.17.issue-1-4.06. [DOI] [PubMed] [Google Scholar]
  2. Andrianakos A. A., Tsichlis P. N., Merikas E. G., Marketos S. G., Sharp J. T., Merikas G. E. Cell-mediated immunity in systemic lupus erythematosus. Clin Exp Immunol. 1977 Oct;30(1):89–96. [PMC free article] [PubMed] [Google Scholar]
  3. Arend W. P., Emmerich T. E., Sturge J. C., Starkebaum G. A. Monocyte-reactive antibodies in patients with systemic lupus erythematosus. Arthritis Rheum. 1977 Jun;20(5):1049–1057. doi: 10.1002/art.1780200503. [DOI] [PubMed] [Google Scholar]
  4. Baum J., Ziff M. Decreased 19S antibody response to bacterial antigens in systemic lupus erythematosus. J Clin Invest. 1969 Apr;48(4):758–767. doi: 10.1172/JCI106033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bresnihan B., Jasin H. E. Suppressor function of peripheral blood mononuclear cells in normal individuals and in patients with systemic lupus erythematosus. J Clin Invest. 1977 Jan;59(1):106–116. doi: 10.1172/JCI108607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Brodman R., Gilfillan R., Glass D., Schur P. H. Influenzal vaccine response in systemic lupus erythematosus. Ann Intern Med. 1978 Jun;88(6):735–740. doi: 10.7326/0003-4819-88-6-735. [DOI] [PubMed] [Google Scholar]
  7. Chiorazzi N., Fu S. M., Montazeri G., Kunkel H. G., Rai K., Gee T. T cell helper defect in patients with chronic lymphocytic leukemia. J Immunol. 1979 Mar;122(3):1087–1090. [PubMed] [Google Scholar]
  8. Evans A. S., Rothfield N. F. E.B. virus and other viral antibodies in systemic lupus erythematosus. Lancet. 1973 May 19;1(7812):1127–1128. doi: 10.1016/s0140-6736(73)90444-3. [DOI] [PubMed] [Google Scholar]
  9. Evans R. L., Faldetta T. J., Humphreys R. E., Pratt D. M., Yunis E. J., Schlossman S. F. Peripheral human T cells sensitized in mixed leukocyte culture synthesize and express Ia-like antigens. J Exp Med. 1978 Nov 1;148(5):1440–1445. doi: 10.1084/jem.148.5.1440. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Faith R. E., Luster M. I., Moore J. A. Chemical separation of helper cell function and delayed hypersensitivity responses. Cell Immunol. 1978 Oct;40(2):275–284. doi: 10.1016/0008-8749(78)90335-0. [DOI] [PubMed] [Google Scholar]
  11. Fauci A. S., Dale D. C. The effect of in vivo hydrocortisone on subpopulations of human lymphocytes. J Clin Invest. 1974 Jan;53(1):240–246. doi: 10.1172/JCI107544. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Fu S. M., Chiorazzi N., Wang C. Y., Montrazeri G., Kunkel H. G., Ko H. S., Gottlieb A. B. Ia-bearing T lymphocytes in man. Their identification and role in the generation of allogeneic helper activity. J Exp Med. 1978 Nov 1;148(5):1423–1428. doi: 10.1084/jem.148.5.1423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Geha R. S., Merler E. Human lymphocyte mitogenic factor: synthesis by sensitized thymus-derived lymphocytes, dependence of expression on the presence of antigen. Cell Immunol. 1974 Jan;10(1):86–104. doi: 10.1016/0008-8749(74)90154-3. [DOI] [PubMed] [Google Scholar]
  14. Geha R. S., Schneeberger E., Rosen F. S., Merler E. Interaction of human thymus-derived and non-thymus-derived lymphocytes in vitro. Induction of proliferation and antibody synthesis in B lymphocytes by a soluble factor released from antigen-stimulated T lymphocytes. J Exp Med. 1973 Nov 1;138(5):1230–1247. doi: 10.1084/jem.138.5.1230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Goodwin J. S., Messner R. P., Bankhurst A. D., Peake G. T., Saiki J. H., Williams R. C., Jr Prostaglandin-producing suppressor cells in Hodgkin's disease. N Engl J Med. 1977 Nov 3;297(18):963–968. doi: 10.1056/NEJM197711032971802. [DOI] [PubMed] [Google Scholar]
  16. Hollinger F. B., Sharp J. T., Lidsky M. D., Rawls W. E. Antibodies to viral antigens in systemic lupus erythematosus. Arthritis Rheum. 1971 Jan-Feb;14(1):1–11. doi: 10.1002/art.1780140102. [DOI] [PubMed] [Google Scholar]
  17. Horowitz S., Borcherding W., Moorthy A. V., Chesney R., Schulte-Wisserman H., Hong R. Induction of suppressor T cells in systemic lupus erythematosus by thymosin and cultured thymic epithelium. Science. 1977 Sep 2;197(4307):999–1001. doi: 10.1126/science.302032. [DOI] [PubMed] [Google Scholar]
  18. Horwitz D. A., Garrett M. A., Craig A. H. Serum effects of mitogenic reactivity in subjects with systemic lupus erythematosus, rheumatoid arthritis and scleroderma. Technical considerations and lack of correlation with anti-lymphocyte antibodies. Clin Exp Immunol. 1977 Jan;27(1):100–110. [PMC free article] [PubMed] [Google Scholar]
  19. Horwitz D. A. Impaired delayed hypersensitivity in systemic lupus erythematosus. Arthritis Rheum. 1972 Jul-Aug;15(4):353–359. doi: 10.1002/art.1780150406. [DOI] [PubMed] [Google Scholar]
  20. Hurd E. R., Dowdle W., Casey H., Ziff M. Virus antibody levels in systemic lupus erythematosus. Arthritis Rheum. 1972 May-Jun;15(3):267–274. doi: 10.1002/art.1780150308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Johnson W. D., Jr, Mei B., Cohn Z. A. The separation, long-term cultivation, and maturation of the human monocyte. J Exp Med. 1977 Dec 1;146(6):1613–1626. doi: 10.1084/jem.146.6.1613. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Kapp J. A., Pierce C. W., Schlossman S., Benacerraf B. Genetic control of immune responses in vitro. V. Stimulation of suppressor T cells in nonresponder mice by the terpolymer L-glutamic acid 60-L-alanine 30-L-tyrosine 10 (GAT). J Exp Med. 1974 Sep 1;140(3):648–659. doi: 10.1084/jem.140.3.648. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Ling N. R., Bishop S., Jefferis Use of antibody-coated red cells for the sensitive detection of antigen and in rosette tests for cells bearing surface immunoglobulins. J Immunol Methods. 1977;15(3):279–289. doi: 10.1016/0022-1759(77)90065-5. [DOI] [PubMed] [Google Scholar]
  24. Louie J. S., Nies K. M., Shoji K. T., Fraback R. C., Abrass C., Border W., Cherry J. D., Imagawa D. Clinical and antibody responses after influenza immunization in systemic lupus erythematosus. Ann Intern Med. 1978 Jun;88(6):790–792. doi: 10.7326/0003-4819-88-6-790. [DOI] [PubMed] [Google Scholar]
  25. MUSCHEL L. H. Systemic lupus erythematosus and normal antibodies. Proc Soc Exp Biol Med. 1961 Mar;106:622–625. doi: 10.3181/00379727-106-26422. [DOI] [PubMed] [Google Scholar]
  26. Moretta L., Ferrarini M., Cooper M. D. Characterization of human T-cell subpopulations as defined by specific receptors for immunoglobulins. Contemp Top Immunobiol. 1978;8:19–53. doi: 10.1007/978-1-4684-0922-2_2. [DOI] [PubMed] [Google Scholar]
  27. Mudawwar F. B., Yunis E. J., Geha R. S. Antigen-specific helper factor in man. J Exp Med. 1978 Oct 1;148(4):1032–1043. doi: 10.1084/jem.148.4.1032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Ristow S. C., Douglas R. G., Jr, Condemi J. J. Influenza vaccination of patients with systemic lupus erythematosus. Ann Intern Med. 1978 Jun;88(6):786–789. doi: 10.7326/0003-4819-88-6-786. [DOI] [PubMed] [Google Scholar]
  29. Rosenthal A. S., Shevach E. M. Function of macrophages in antigen recognition by guinea pig T lymphocytes. I. Requirement for histocompatible macrophages and lymphocytes. J Exp Med. 1973 Nov 1;138(5):1194–1212. doi: 10.1084/jem.138.5.1194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Rosenthal C. J., Franklin E. C. Depression of cellular-mediated immunity in systemic lupus erythematosus. relation to disease activity. Arthritis Rheum. 1975 May-Jun;18(3):207–217. doi: 10.1002/art.1780180303. [DOI] [PubMed] [Google Scholar]
  31. Senyk G., Hadley W. K., Attias M. R., Talal N. Cellular immunity in systemic lupus erythematosus. Arthritis Rheum. 1974 Sep-Oct;17(5):553–562. doi: 10.1002/art.1780170509. [DOI] [PubMed] [Google Scholar]
  32. Utermohlen V., Winfield J. B., Zabriskie J. B., Kunkel H. G. A depression of cell-mediated immunity to measles antigen in patients with systemic lupus erythematosus. J Exp Med. 1974 Apr 1;139(4):1019–1024. doi: 10.1084/jem.139.4.1019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Utsinger P. D. Lymphocyte responsiveness in systemic lupus erythematosus. Arthritis Rheum. 1976 Jan-Feb;19(1):88–92. doi: 10.1002/art.1780190115. [DOI] [PubMed] [Google Scholar]
  34. Wernet P., Kunkel H. G. Antibodies to a specific surface antigen of T cells in human sera inhibiting mixed leukocyte culture reactions. J Exp Med. 1973 Oct 1;138(4):1021–1026. doi: 10.1084/jem.138.4.1021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Williams G. W., Steinberg A. D., Reinertsen J. L., Klassen L. W., Decker J. L., Dolin R. Influenza immunization in systemic lupus eruthematosus. A double-blind trial. Ann Intern Med. 1978 Jun;88(6):729–734. doi: 10.7326/0003-4819-88-6-729. [DOI] [PubMed] [Google Scholar]
  36. Wilson C. B., Dixon F. J., Evans A. S., Glassock R. J. Antiviral antibody responses in patients with renal diseases. Clin Immunol Immunopathol. 1973 Nov;2(1):121–132. doi: 10.1016/0090-1229(73)90042-1. [DOI] [PubMed] [Google Scholar]
  37. Yano A., Schwartz R. H., Paul W. E. Antigen presentation in the murine T-lymphocyte proliferative response. I. Requirement for genetic identity at the major histocompatibility complex. J Exp Med. 1977 Sep 1;146(3):828–843. doi: 10.1084/jem.146.3.828. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. ZINGALE S. B., SANCHEZAVALOS J. C., ANDRADA J. A., STRINGA S. G., MANNI J. A. APPEARANCE OF ANTICOAGULANT FACTORS AND CERTAIN "AUTOIMMUNE" ANTIBODIES FOLLOWING ANTIGENIC STIMULATION WITH BLOOD GROUP SUBSTANCES IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS. Arthritis Rheum. 1963 Oct;6:581–598. doi: 10.1002/art.1780060503. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES